Clinical trial
Randomised Control Trial of Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia
NCT07404319 is registered in ClinicalTrials.gov with Kit Wa Chan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Control Trial of Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia
- Lead sponsor
- Kit Wa Chan
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 23, 2026
- Completion date
- January 30, 2028
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment, schizophrenia, treatment resistant schizophrenia